198 related articles for article (PubMed ID: 38482176)
41. Generalized pustular psoriasis in Brazil: A public claims database study.
Duarte GV; Esteves de Carvalho AV; Romiti R; Gaspar A; Gomes de Melo T; Soares CP; Aguirre AR
JAAD Int; 2022 Mar; 6():61-67. PubMed ID: 35059660
[TBL] [Abstract][Full Text] [Related]
42. [Remission of recalcitrant generalized pustular psoriasis under interleukin-36 receptor inhibitor spesolimab].
Müller VL; Kreuter A
Dermatologie (Heidelb); 2023 May; 74(5):356-359. PubMed ID: 36943426
[TBL] [Abstract][Full Text] [Related]
43. Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United States.
Hanna ML; Singer D; Bender SD; Valdecantos WC; Wu JJ
Curr Med Res Opin; 2021 Oct; 37(10):1697-1703. PubMed ID: 34289766
[TBL] [Abstract][Full Text] [Related]
44. Successful treatment of recalcitrant generalized pustular psoriasis of pregnancy with spesolimab.
Yang C; Wang Y; Li R; Tu P; Wang R
J Dermatolog Treat; 2024 Dec; 35(1):2334791. PubMed ID: 38565205
[TBL] [Abstract][Full Text] [Related]
45. Flare-up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination.
Yatsuzuka K; Murakami M; Kuroo Y; Fukui M; Yoshida S; Muto J; Shiraishi K; Sayama K
J Dermatol; 2022 Apr; 49(4):454-458. PubMed ID: 34862669
[TBL] [Abstract][Full Text] [Related]
46. Elderly-Onset Generalized Pustular Psoriasis without a Previous History of Psoriasis Vulgaris.
Aizu T; Matsui A; Takiyoshi N; Akasaka E; Kaneko T; Nakano H; Sugiura K; Akiyama M; Sawamura D
Case Rep Dermatol; 2015; 7(2):187-93. PubMed ID: 26351429
[TBL] [Abstract][Full Text] [Related]
47. Epidemiology, Characteristics of Disease, and Unmet Needs of Patients with Generalized Pustular Psoriasis: A Large Italian Delphi Consensus.
Prignano F; Atzori L; Bellinato F; Damiani G; Galeone C; Mariani P; Potenza C; Scopinaro A; Piaserico S; Fabbrocini G;
Dermatology; 2024; 240(3):414-424. PubMed ID: 38493762
[TBL] [Abstract][Full Text] [Related]
48. Prevalence and incidence of generalized pustular psoriasis in Sweden: a population-based register study.
Löfvendahl S; Norlin JM; Schmitt-Egenolf M
Br J Dermatol; 2022 Jun; 186(6):970-976. PubMed ID: 34978071
[TBL] [Abstract][Full Text] [Related]
49. A narrative review of the socioeconomic burden associated with generalised pustular psoriasis.
Zimmermann TM; Hofmann P; Chiu GR
Exp Dermatol; 2023 Aug; 32(8):1219-1226. PubMed ID: 37309747
[TBL] [Abstract][Full Text] [Related]
50.
Kantaputra P; Daroontum T; Chuamanochan M; Chaowattanapanit S; Kiratikanon S; Choonhakarn C; Intachai W; Olsen B; Tongsima S; Ngamphiw C; Pontisso P; Cox TC; Ounjai P
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833193
[TBL] [Abstract][Full Text] [Related]
51. Clinical Disease Measures in Generalized Pustular Psoriasis.
Burden AD; Choon SE; Gottlieb AB; Navarini AA; Warren RB
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):39-50. PubMed ID: 35061231
[TBL] [Abstract][Full Text] [Related]
52. Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study.
Bellinato F; Gisondi P; Marzano AV; Piaserico S; De Simone C; Damiani G; Argenziano G; Venturini M; Dapavo P; Costanzo A; Megna M; Prignano F; Burlando M; Satolli F; Carugno A; Pezzolo E; Romanelli M; Cuccia A; Girolomoni G
Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112652
[TBL] [Abstract][Full Text] [Related]
53. Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study.
Navarini AA; Prinz JC; Morita A; Tsai TF; Viguier MA; Li L; Thoma C; Sivalingam M; Lebwohl MG
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):730-736. PubMed ID: 36527385
[TBL] [Abstract][Full Text] [Related]
54. Characteristics and Burdens of Disease in Patients from Beijing with Generalized Pustular Psoriasis and Palmoplantar Pustulosis: Multicenter Retrospective Cohort Study Using a Regional Database.
Wang HM; Xu JM; Jin HZ
Am J Clin Dermatol; 2023 Nov; 24(6):991-1002. PubMed ID: 37386353
[TBL] [Abstract][Full Text] [Related]
55. Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence.
Bhutani T; Farberg AS
Dermatol Ther (Heidelb); 2024 Feb; 14(2):341-360. PubMed ID: 38363460
[TBL] [Abstract][Full Text] [Related]
56. Generalized pustular psoriasis-like widespread eruption following COVID-19 infection in a patient with spondyloarthropathy on adalimumab.
Kamal K; Riew GJ; Hijaz B; Helfgott SM; Laga AC; Nambudiri VE
Exp Dermatol; 2024 Jan; 33(1):e14889. PubMed ID: 37452555
[TBL] [Abstract][Full Text] [Related]
57. Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists.
Vilarrasa E; Rivera R; Eiris N; Carretero G; de la Cueva P; Carrascosa JM
Actas Dermosifiliogr; 2024 May; 115(5):449-457. PubMed ID: 37925068
[TBL] [Abstract][Full Text] [Related]
58. Clinical features and course of generalized pustular psoriasis in Korea.
Jin H; Cho HH; Kim WJ; Mun JH; Song M; Kim HS; Ko HC; Kim MB; Kim H; Kim BS
J Dermatol; 2015 Jul; 42(7):674-8. PubMed ID: 25819215
[TBL] [Abstract][Full Text] [Related]
59. Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.
Krueger J; Puig L; Thaçi D
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):51-64. PubMed ID: 35061230
[TBL] [Abstract][Full Text] [Related]
60. Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP).
Burden AD; Mrowietz U; Skalicky AM; Rentz AM; Esser D; Gloede T; Thoma C; Menter A
Dermatol Ther (Heidelb); 2022 Jun; 12(6):1367-1381. PubMed ID: 35590037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
